Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NiCE Lock Solution for CVC Infection Prevention
NCT02577718Phase 2Completed
- Sponsor
- Novel Anti-Infective Technologies
- Start
- Nov 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitroglycerin, trisodium citrate, ethanol in central line-associated bloodstream infection (CLABSI), sponsored by Novel Anti-Infective Technologies. Started Nov 2015; status: completed.
02
Drugs
nitroglycerintrisodium citrateethanol
03
Conditions
central line-associated bloodstream infection (CLABSI)
Beyond the preview
Go deeper on NCT02577718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02577718.